Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmalex Nordic ApS
APS
Active
CVR 37541540
Lyngby Hovedgade 10C, 2800
Kongens Lyngby
Activities of holding companies
·
NACE 6421
Est. 2016 · 10 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Activities of holding companies
/
Pharmalex Nordic ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
YM
YES Multinational Holding Company GmbH
Founder
Founder
2016
CG
Christopher Gauglitz
Management
Management
2023
ÅP
Åsa Pihlblad
Chief Executive Officer
Chief Executive Officer
2024
Former (5)
AL
Anette Langgaard Jacobsen
Management
Management
2016 – 2018
SB
Solveig Blomvik
Management
Management
2016 – 2018
LM
Laurent Maurice Robert Couston
Management
Management
2023 – 2024
DR
Dr. Raphael Troost
Chief Executive Officer
Chief Executive Officer
2016 – 2016
TT
Torben Thers Nørgaard
Chief Executive Officer
Chief Executive Officer
2017 – 2024
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
AmerisourceBergen International B.V.
Individual
100%
100%
2023
JAF INVEST ApS
Company
20–24.99%
20–24.99%
2016
PharmaLex GmbH
Individual
100%
100%
2020
Vanturi ApS
Company
5–9.99%
5–9.99%
2016
AB Netherlands Pharma Investments B.V.
Individual
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Pharmalex Nordic ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
